Hydroxyprogesterone Caproate Injection USP 2 ml
- Hydroxyprogesterone Caproate Injection USP 2 ml
Therapeutic Class: Hormonal Therapy
Dosage Forms: Injectables
Brand Name: Pogastin™
How it works?
Uses of Hydroxyprogesterone Caproate Injection USP 2 ml
- Preterm birth prevention → Indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of spontaneous singleton preterm birth.
- Gestational outcome improvement → Effectiveness is based on increasing the proportion of women delivering beyond 37 weeks of gestation.
- Emergency limitation → Not intended for women with multiple gestations or other risk factors for preterm birth.
- Clinical scope → No controlled trials demonstrate direct neonatal benefit (mortality/morbidity), but maternal gestational extension is documented.
Precautions of Hydroxyprogesterone Caproate Injection USP 2 ml
Thromboembolic Disorders
Discontinue Pogastin if an arterial or deep venous thrombotic or thromboembolic event occurs.
Allergic Reactions
Allergic reactions, including urticaria, pruritus, and angioedema, have been reported with use of Pogastin. Consider discontinuing the drug if such reactions occur.
Decrease in Glucose Tolerance
A decrease in glucose tolerance has been observed in some patients on progestin treatment. The mechanism of this decrease is not known. Carefully monitor prediabetic and diabetic women while they are receiving Pogastin.
Fluid Retention
Because progestational drugs may cause some degree of fluid retention, carefully monitor women with conditions that might be influenced by this effect (e.g., preeclampsia, epilepsy, migraine, asthma, cardiac or renal dysfunction).
Depression
Monitor women who have a history of clinical depression and discontinue Pogastin if clinical depression recurs.
Jaundice
Carefully monitor women who develop jaundice while receiving Pogastin and consider whether the benefit of use warrants continuation.
Hypertension
Carefully monitor women who develop hypertension while receiving Pogastin and consider whether the benefit of use warrants continuation.
Dosages administration of Hydroxyprogesterone Caproate Injection USP 2 ml
Administer intramuscularly at a dose of 250 mg (1 ml) once weekly (every 7 days) by a healthcare provider
Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation
Continue administration once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first
Side effects of Hydroxyprogesterone Caproate Injection USP 2 ml
Hydroxyprogesterone Caproate Injection most often causes injection site reactions (pain, swelling, rash, pruritus). Post marketing reports highlight additional systemic, reproductive, and respiratory effects. Patients should consult a doctor if severe or persistent side effects occur.
Storage instruction of Hydroxyprogesterone Caproate Injection USP 2 ml
Store below 30°C. Protect from light. Do not freeze.
Once opened, use immediately and discard any unused contents.
Do not use the solution if any foreign particles are observed.
Keep the medicine out of reach and sight of children.
For human use only.
Packing details of Hydroxyprogesterone Caproate Injection USP 2 ml
2 ml amber-colored ampoule along with package insert. 500 mg/ 2 ml
interested? let’s talk.
Contact us directly to receive full information on the product, the formulation, the science behind it, stability data, and more. Our Business Development Manager is a click away.
Reliable GMP Certified Hydroxyprogesterone Caproate Injection USP 2 ml Manufacturer
Conical Pharmaceuticals, headquartered in Ahmedabad, India, is a GMP‑certified manufacturer & exporter of Hydroxyprogesterone Caproate Injection USP 2 ml, Our company delivering premium pharmaceutical and nutraceutical solutions worldwide.
This trusted progestin therapy is indicated to reduce the risk of preterm birth in women with a singleton pregnancy and a history of spontaneous preterm birth. With a strong planning and distribution network across Central Africa, Central America, and the CIS Region, and expanding into Nigeria, Ghana, Zambia, Zimbabwe, Kenya, the Philippines, Singapore, and Afghanistan, we ensure reliable supply and smooth market entry.
Importers benefit from complete regulatory dossier support, including GMP Certification, COPP, COA, and Free Sale Certificates. We also provide third‑party contract manufacturing, private labelling, and custom formulation options, empowering partners to launch their own brands with tailored solutions.
As a trusted contract manufacturer, Conical Pharmaceuticals supplies to international importers, large distributors, pharmacy chains, and hospitals. With advanced R&D, flexible MOQ options, and consistent quality assurance, we enable partners to expand their market presence while delivering effective, high‑quality pharmaceutical solutions worldwide.
CUSTOM PACKAGING
Options available in size and style to meet your exact specifications and branding needs
SAMPLES AVAILABLE
Test before committing to bulk orders with complimentary samples for quality verification
LEAD TIME
45–60 days for timely delivery, ensuring reliable supply chain management
SHELF LIFE
Shelf Life: 24 months.
Frequently Asked Questions
Questions are useful tools, they open lines of communication; give us information; improve interactions, facilitate analysis, and many more.
-
Conical Pharmaceuticals,, is a GMP‑certified manufacturer & exporter of Hydroxyprogesterone Caproate Injection also Specialized in third party contract manufacturing.
-
Conical Pharmaceutical provides all the regulatory document includes GMP, COPP, COA, and Free Sale Certificates, for smooth approvals.
-
Yes, we provide private labelling, contract manufacturing, and custom formulation options.
-
Conical Pharmaceutical is planning to export Hydroxyprogesterone Caproate Injection into Central Africa, Central America, CIS Region, plus expansion into Nigeria, Ghana, Zambia, Zimbabwe, Kenya, the Philippines, Singapore, and Afghanistan.
-
Pain, swelling, rash, itching at the injection site; urticaria, nausea, and diarrhea may also occur.
-
Side effect include fatigue, fever, vomiting, headache, dizziness, urinary tract infection, cervical changes, and breathing discomfort.